Literature DB >> 9759839

CD148: a receptor-type protein tyrosine phosphatase involved in the regulation of human T cell activation.

S G Tangye1, J H Phillips, L L Lanier, J E de Vries, G Aversa.   

Abstract

Following ligation of the TCR and costimulatory molecules such as CD28, T cells proliferate and secrete cytokines. Several other cell surface molecules have been identified that are capable of augmenting activation mediated via the TCR. These include CD2, CD27, CD40 ligand, and signaling lymphocytic activation molecule. Here, we have characterized the expression and function of CD148, a recently identified receptor-type protein tyrosine phosphatase. CD148 is expressed at low levels on resting T cells, but is up-regulated following in vitro activation. Cross-linking CD148 with immobilized anti-CD148 mAb induced vigorous proliferation of anti-CD3 mAb-activated, highly purified peripheral blood T cells in an IL-2-dependent, cyclosporin A-sensitive manner. This effect was greatest after 8 days of in vitro culture, suggesting that this molecule is involved in the latter stages of a T cell response. CD148-induced proliferation was significantly greater for CD8+ T cells than for CD4+ T cells. Thus, CD148 is a receptor-type protein tyrosine phosphatase involved in the activation of T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9759839

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  Evaluating function of transmembrane protein tyrosine phosphatase CD148 in lymphocyte biology.

Authors:  Thomas R Harrod; Louis B Justement
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Protein tyrosine phosphatase CD148-mediated inhibition of T-cell receptor signal transduction is associated with reduced LAT and phospholipase Cgamma1 phosphorylation.

Authors:  J E Baker; R Majeti; S G Tangye; A Weiss
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

3.  A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesis.

Authors:  Takamune Takahashi; Keiko Takahashi; Raymond L Mernaugh; Nobuo Tsuboi; Hua Liu; Thomas O Daniel
Journal:  Blood       Date:  2006-04-04       Impact factor: 22.113

4.  Inhibition of T-cell activation by syndecan-4 is mediated by CD148 through protein tyrosine phosphatase activity.

Authors:  Jin-Sung Chung; Ponciano D Cruz; Kiyoshi Ariizumi
Journal:  Eur J Immunol       Date:  2011-05-09       Impact factor: 5.532

5.  Regulation of Src family kinases involved in T cell receptor signaling by protein-tyrosine phosphatase CD148.

Authors:  Ondrej Stepanek; Tomas Kalina; Peter Draber; Tereza Skopcova; Karel Svojgr; Pavla Angelisova; Vaclav Horejsi; Arthur Weiss; Tomas Brdicka
Journal:  J Biol Chem       Date:  2011-05-04       Impact factor: 5.157

Review 6.  CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells.

Authors:  Michelle L Hermiston; Julie Zikherman; Jing W Zhu
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

7.  The DC-HIL/syndecan-4 pathway inhibits human allogeneic T-cell responses.

Authors:  Jin-Sung Chung; Makoto Bonkobara; Mizuki Tomihari; Ponciano D Cruz; Kiyoshi Ariizumi
Journal:  Eur J Immunol       Date:  2009-04       Impact factor: 5.532

Review 8.  Regulation of TCR signalling by tyrosine phosphatases: from immune homeostasis to autoimmunity.

Authors:  Stephanie M Stanford; Novella Rapini; Nunzio Bottini
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

9.  The tyrosine phosphatase CD148 is excluded from the immunologic synapse and down-regulates prolonged T cell signaling.

Authors:  Joseph Lin; Arthur Weiss
Journal:  J Cell Biol       Date:  2003-08-11       Impact factor: 10.539

10.  Identification of functional human splenic memory B cells by expression of CD148 and CD27.

Authors:  S G Tangye; Y J Liu; G Aversa; J H Phillips; J E de Vries
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.